- OUTLOOK
Oncogene-specific advocacy groups bring a patient-centric perspective to studies of lung cancer
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 587, S16-S17 (2020)
doi: https://doi.org/10.1038/d41586-020-03150-2
This article is part of Nature Outlook: Lung cancer, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Parikh, D. A. et al. JCO Oncol. Pract. 16, e183–e189 (2019).
McCoach, C. E. et al. Clin. Cancer Res. 24, 3334–3347 (2018).
Neel, D. S. et al. Cancer Res. 79, 546–556 (2019).